The stock has a 36-month beta value of -0.10. Opinions on the stock are mixed, with 0 analysts rating it as a “buy”, 1 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for OKYO is 24.57M, and at present, short sellers hold a 0.78% of that float. On July 04, 2025, the average trading volume of OKYO was 154.97K shares.
OKYO stock’s latest price update
OKYO Pharma Limited (NASDAQ: OKYO) has experienced a decline in its stock price by -4.47% compared to its previous closing price of $2.91. However, the company has seen a gain of 14.64% in its stock price over the last five trading days. proactiveinvestors.com reported 2025-06-11 that Shares of OKYO Pharma Ltd (NASDAQ:OKYO) have nearly doubled since the start of the year, fueled by a string of clinical and regulatory milestones that may pave the way for a transformative treatment in the underserved field of ocular pain. In a new note research report, Goldman Small Cap Research raised its price target on the stock to $8, up from $5, citing strong momentum, accelerated clinical progress, and growing interest from patients and clinicians alike in the company’s lead drug candidate, urcosimod.
OKYO’s Market Performance
OKYO Pharma Limited (OKYO) has experienced a 14.64% rise in stock performance for the past week, with a 48.66% rise in the past month, and a 122.40% rise in the past quarter. The volatility ratio for the week is 6.96%, and the volatility levels for the past 30 days are at 11.96% for OKYO. The simple moving average for the last 20 days is 16.09% for OKYO’s stock, with a simple moving average of 109.91% for the last 200 days.
OKYO Trading at 44.71% from the 50-Day Moving Average
After a stumble in the market that brought OKYO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.61% of loss for the given period.
Volatility was left at 11.96%, however, over the last 30 days, the volatility rate increased by 6.96%, as shares surge +47.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +107.46% upper at present.
During the last 5 trading sessions, OKYO rose by +14.64%, which changed the moving average for the period of 200-days by +169.90% in comparison to the 20-day moving average, which settled at $2.39. In addition, OKYO Pharma Limited saw 124.19% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
N/A, the N/A of OKYO Pharma Limited, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for OKYO
The total capital return value is set at 0.0%.
Based on OKYO Pharma Limited (OKYO), the company’s capital structure generated -0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -0.13.
Currently, EBITDA for the company is 15745.87 with net debt to EBITDA at 295.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.28.
Conclusion
To sum up, OKYO Pharma Limited (OKYO) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
